Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 45.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE versus POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5 AND SODIUM CHLORIDE 0 45.
MAGNESIUM SULFATE vs POTASSIUM CHLORIDE 10MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Potassium chloride is a potassium supplement that replaces potassium ions lost from the body. Dextrose 5% provides a source of calories and may enhance potassium uptake into cells via insulin-mediated mechanisms. Sodium chloride 0.45% provides sodium and chloride to maintain electrolyte balance.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
Intravenous infusion; 10 mEq potassium chloride in 1000 mL of solution (D5W + 0.45% NaCl) at a rate not exceeding 10 mEq/hour and total daily dose not exceeding 200 mEq, with continuous ECG monitoring. Typical adult dose: 10-20 mEq infused over 1-2 hours, repeated as needed based on serum potassium levels.
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateNone Documented
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
Not applicable as potassium is an electrolyte; serum half-life varies with distribution; redistribution half-life approximately 1-1.5 hours.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Primarily renal (90% excreted in urine as potassium ions), with minimal fecal (<5%) and negligible biliary elimination.
Category C
Category A/B
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."